Correlation Between Diffusion Pharmaceuticals and Aeterna Zentaris
Can any of the company-specific risk be diversified away by investing in both Diffusion Pharmaceuticals and Aeterna Zentaris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diffusion Pharmaceuticals and Aeterna Zentaris into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diffusion Pharmaceuticals and Aeterna Zentaris, you can compare the effects of market volatilities on Diffusion Pharmaceuticals and Aeterna Zentaris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diffusion Pharmaceuticals with a short position of Aeterna Zentaris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diffusion Pharmaceuticals and Aeterna Zentaris.
Diversification Opportunities for Diffusion Pharmaceuticals and Aeterna Zentaris
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Diffusion and Aeterna is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Diffusion Pharmaceuticals and Aeterna Zentaris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aeterna Zentaris and Diffusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diffusion Pharmaceuticals are associated (or correlated) with Aeterna Zentaris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aeterna Zentaris has no effect on the direction of Diffusion Pharmaceuticals i.e., Diffusion Pharmaceuticals and Aeterna Zentaris go up and down completely randomly.
Pair Corralation between Diffusion Pharmaceuticals and Aeterna Zentaris
Given the investment horizon of 90 days Diffusion Pharmaceuticals is expected to under-perform the Aeterna Zentaris. But the stock apears to be less risky and, when comparing its historical volatility, Diffusion Pharmaceuticals is 1.24 times less risky than Aeterna Zentaris. The stock trades about -0.1 of its potential returns per unit of risk. The Aeterna Zentaris is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 1,544 in Aeterna Zentaris on August 30, 2024 and sell it today you would lose (930.00) from holding Aeterna Zentaris or give up 60.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 36.99% |
| Values | Daily Returns |
Diffusion Pharmaceuticals vs. Aeterna Zentaris
Performance |
| Timeline |
| Diffusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Aeterna Zentaris |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Diffusion Pharmaceuticals and Aeterna Zentaris Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Diffusion Pharmaceuticals and Aeterna Zentaris
The main advantage of trading using opposite Diffusion Pharmaceuticals and Aeterna Zentaris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diffusion Pharmaceuticals position performs unexpectedly, Aeterna Zentaris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aeterna Zentaris will offset losses from the drop in Aeterna Zentaris' long position.| Diffusion Pharmaceuticals vs. Bio Path Holdings | Diffusion Pharmaceuticals vs. Capricor Therapeutics | Diffusion Pharmaceuticals vs. NextCure | Diffusion Pharmaceuticals vs. Tonix Pharmaceuticals Holding |
| Aeterna Zentaris vs. Pulmatrix | Aeterna Zentaris vs. Bio Path Holdings | Aeterna Zentaris vs. Moleculin Biotech | Aeterna Zentaris vs. Adial Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |